Multiple Brands of Lubricant Eye Ointments Recalled Over Infection Risk from Unsterile Conditions at Indian Plant

A recent recall of multiple brands of lubricant eye ointments has been initiated due to the discovery of unsterile conditions at an Indian manufacturing plant. The U.S. Food and Drug Administration (FDA) revealed that the products, manufactured by Brassica Pharma Pvt. in Thane, Maharashtra, may pose a risk of infection to consumers.

What are the infected eye ointments?

The affected eye ointments, sold nationwide by retailers like CVS Health and Walmart, include four products under the brands Equate, CVS Health and AACE Pharmaceuticals. These products have expiration dates ranging from April 2024 to September 2025. The specific recalled products are as follows:

• Equate Lubricant Eye Ointment in a 3.5-gram tube
• Equate Style Lubricant Eye Ointment in a 3.5-gram tube
• CVS Health Lubricant Eye Ointment in a 3.5-gram tube
• Lubricant PM Ointment in a 3.5 gram tube

Consumers are advised to stop using these eye ointments and can return them to the place of purchase for a refund. For inquiries and further information, individuals can contact the manufacturer at 1-833-225-9564 or via email at info@brassicapharma.com.

This recall follows a deadly outbreak of eye infections connected to artificial tears produced by another Indian company last year. The product EzriCare artificial tears, among the brands recalled by Delsam Pharma of Chennai, India, led to 81 reported cases of infections across 18 states, resulting in four deaths and several instances of vision loss.

In response to these concerning incidents, the FDA has cautioned against the use of copycat eye drops due to the associated risk of infection. Consumers are urged to prioritize their health and safety by refraining from using the recalled eye ointments and seeking medical advice if they have already used these products and are experiencing any adverse effects.

The recent recall of multiple lubricant eye ointment brands emphasizes the critical importance of maintaining sterile conditions in pharmaceutical manufacturing. Authorities are actively working to ensure the safety and well-being of consumers, and it is essential for individuals to stay informed and take appropriate action to protect their health.